Claudin 8 Contributes to Malignant Proliferation in Human Osteosarcoma U2OS Cells

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Human osteosarcoma (OS) is a common primary bone cancer with poorly understood molecular mechanisms.
• Tight junction proteins are implicated in tumorigenesis, suggesting potential roles in OS development.

Purpose of the Study:

• To investigate the specific role of Claudin 8 (CLDN8) in the molecular pathogenesis of human osteosarcoma.
• To evaluate CLDN8's impact on OS cell viability, proliferation, and cell cycle progression.

Main Methods:

• Utilized lentivirus-based short hairpin RNA (shRNA) to specifically deplete endogenous CLDN8 expression in U2OS and SW1353 OS cell lines.
• Assessed cell viability and proliferation using standard assays.
• Employed flow cytometry and apoptosis assays to determine effects on cell cycle (G1-S transition) and programmed cell death.

Main Results:

• CLDN8 expression was significantly reduced (97.7% in U2OS, 89.3% in SW1353) following shRNA treatment.
• CLDN8 depletion resulted in a marked decrease in OS cell viability and proliferation.
• Knockdown of CLDN8 induced G1-S cell cycle arrest and promoted apoptosis in U2OS cells.

Conclusions:

• Claudin 8 (CLDN8) plays a critical role in promoting osteosarcoma cell proliferation in vitro.
• CLDN8 functions by regulating cell cycle progression and inhibiting apoptosis.
• Targeting CLDN8 presents a promising novel therapeutic strategy for human osteosarcoma treatment.